期刊文献+

特发性息肉状脉络膜血管病变治疗研究进展 被引量:1

Progress of treatment for idiopathicpolypoidal choroidal vasculopathy
下载PDF
导出
摘要 特发性息肉状脉络膜血管病变(idiopathicpolypoidal choroidal vasculopathy,IPCV)是一种以脉络膜末端息肉样血管扩张、异常分支血管网形成为特点的视网膜疾病,常见的临床表现为视网膜下出血或液体积聚、持续性渗漏、反复发作的浆液血液性视网膜色素上皮脱离(pigment epithelial detachment,PED)或神经感觉层脱离。近年来,对于本病的治疗研究越发得到重视,也取得了不少进展。然而,IPCV的最佳治疗仍然存在争议,本文将就这一问题对近年来发表的关于特发性息肉状脉络膜血管病变治疗方案的论文进行整理综述。 Idiopathicpolypoidal choroidal vasculopathy (IPCV) is a retinal disease which is characterized by the choroid presence of polyp-like lesions and branching vascular network(BVN). The clinical manifestations of PCV are subretinal hemorrhage or fluid accumulation,persistent leakage,recurrently serous pigment epithelial detachment (PED) or serous neurosensory detachment. In recent years, more attention has been paid to the treatment of the disease and considerable progress has been made, however, it remains just controversial enough to getting the best treatment of PCV. Aiming at the problem, this paper gives a brief review of the treatment of IPCV published in recent years.
作者 李莎 彭惠 Li Sha;Peng Hui(Department of Ophthalmology, The First Affiliated Hospital of Chongqing Medical Universit;Chongqing Key Laboratory of Ophthalmolog;Chongqing Eye Institut)
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2018年第7期984-987,共4页 Journal of Chongqing Medical University
基金 国家自然科学基金面上资助项目(编号:81670881)
关键词 特发性息肉样脉络膜血管病变 个体化治疗 联合疗法 idiopathicpolypoidal ehoroidal vasculopathy individualized therapy combined therapy
  • 相关文献

参考文献2

二级参考文献40

  • 1Koh AH,Chen LJ,Chen SJ,et al.Polypoidal choroidal vasculopathy:evidence-based guidelines for clinical diagnosis and treatment[J].Retina,2013,33(4):686-716.DOI:10.1097/ IAE.0b013e3182852446. 被引量:1
  • 2Leal S,Silva R,Figueira J,et al.Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy;results after 3 years of follow-up[J].Retina,2010,30(8):1197-1205.DOI:10.1097/IAE.0b013e3181d37486. 被引量:1
  • 3Akaza E,Yuzawa M,Mori R.Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy[J]. Jpn J Ophthalmol,2011,55(1):39-44.DOI:10.1007/sl0384-010-0886-x. 被引量:1
  • 4Michels S,Schmidt-Erfurth U.Sequence of early vascular events after photodynamic therapy[J].Invest Ophthalmol Vis Sci,2003,44(5):2147-2154. 被引量:1
  • 5Schlotzer-Schrehardt U,Viestenz A,Naumarm GO,et al.Dose- related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes[J].Graefe's ArcVi Clin Exp Ophthalmol,2002,240(9)-748-757. 被引量:1
  • 6Schmidt-Erfurth U,Schlotzer-Schrehard U,Cursiefen C,et al. Influence of photodynamic therapy on expression of vascular endothelial growth factor(VEGF),VEGF receptor 3,and pigment epithelium-derived factor[J].Invest Ophthalmol Vis Sci,2003,44(10):4473-4480. 被引量:1
  • 7Alshahrani ST,Al SH,Kahtani ES,et al.Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type I neovascular growth pattern [J]. CHn Ophthalmol,2014,8:1689-1695.DOI:10.2147/OPTH. S68471. 被引量:1
  • 8Kokame OT.Polypoidal choroidal vasculopathy - a type I polypoidal subretinal neovasculopathy[J].Open Ophthalmol],2013,7:82-84.DOI:10.2174/1874364101307010082. 被引量:1
  • 9Matsuoka M,Ogata N,Otsuji T,et al.Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy[J].Br J Ophthalmol,2004,88(6):809-815.DOI:10.2174/1874364101307010082. 被引量:1
  • 10Tong J P,Chan WM,Liu DT,et al.Aqueous humor levels of vascular endothelial growth factor and pigment epithelium- derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization[J].Am J Ophthalmol,2006,141(3):456-462. 被引量:1

共引文献2

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部